Interleukin-24 protects against liver injury in mouse models
Interleukin-24 (IL-24) binds to two kinds of receptor complexes, namely IL-20R1/IL-20R2 and IL-20R2/IL-22R1, which are also bound by IL-20. IL-20 plays a detrimental role in liver fibrosis. Due to the sharing of receptor complexes, we aimed to determine whether IL-24 also participates in liver fibro...
Gespeichert in:
| Veröffentlicht in: | EBioMedicine 2021-02, Vol.64, p.103213-103213, Article 103213 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 103213 |
|---|---|
| container_issue | |
| container_start_page | 103213 |
| container_title | EBioMedicine |
| container_volume | 64 |
| creator | Wang, Hsiao-Hsuan Huang, Jian-Hao Sue, Min-Hao Ho, Wei-Chih Hsu, Yu-Hsiang Chang, Kung-Chao Chang, Ming-Shi |
| description | Interleukin-24 (IL-24) binds to two kinds of receptor complexes, namely IL-20R1/IL-20R2 and IL-20R2/IL-22R1, which are also bound by IL-20. IL-20 plays a detrimental role in liver fibrosis. Due to the sharing of receptor complexes, we aimed to determine whether IL-24 also participates in liver fibrosis.
Clinical biopsy specimens from various stages of liver fibrosis were used to analyze IL-24 expression. IL-24 protein was administered to mice with thioacetamide (TAA)-induced liver injury. The direct effects of IL-24 on mouse primary hepatocytes or hepatic stellate cells (HSCs) were analyzed. Wild-type, IL-20R1-, and IL20R2-deficient mice were used to establish a model of acute TAA-induced liver injury.
Among patients with more severe liver fibrosis, there was a reduced IL-24/IL-20 ratio. Administration of IL-24 protein protected mice from TAA-induced liver injury and reduction of liver inflammation by antioxidant effects. IL-24 protected hepatocytes from TAA-induced apoptosis and prevented liver fibrosis through the inhibition of the HSCs activation. The protective role of IL-24 acted on liver cells were mainly IL-20R1-independent. IL-20R2-deficient mice exhibited more severe liver injury upon TAA treatment, thus confirming the protective role of IL-24.
IL-24 plays a key protective role in the progression of liver injury and has therapeutic potential for treating liver injuries.
This work was supported by the Ministry of Science and Technology of Taiwan (MOST 106–2320-B-006–024) and Taiwan Liver Disease Prevention & Treatment Research Foundation. |
| doi_str_mv | 10.1016/j.ebiom.2021.103213 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_webof</sourceid><recordid>TN_cdi_webofscience_primary_000624441600011CitationCount</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2352396421000062</els_id><doaj_id>oai_doaj_org_article_dc0d72cbd28d42c3821f37cb3793da0b</doaj_id><sourcerecordid>2483813544</sourcerecordid><originalsourceid>FETCH-LOGICAL-c525t-27f2f170128d23565f358442df91728ee5a95564bed2cecec2416656b2cde3713</originalsourceid><addsrcrecordid>eNqNUl2L1DAULaK4y7q_QJA-CtIxn20HVFgGPwYWfNHnkCa3Y2qbjEk6sv_eO9tx2H0RCeSGm3POvbknRfGSkhUltH47rKBzYVoxwihmOKP8SXHJuGQVX9fi6YPzRXGd0kAIoVJgsn1eXHAuSdsIeVm82_oMcYT5p_MVE-U-hgwmp1LvtPMpl6M7QCydH-Z4h6GcwpwAdwtjelE86_WY4PoUr4rvnz5-23ypbr9-3m5ubisjmcwVa3rW04ZQ1lpsoJY9diEEs_2aNqwFkHotZS06sMwALiZoXcu6Y8YCbyi_KraLrg16UPvoJh3vVNBO3SdC3CkdszMjKGuIbZjpLNYSzPCW0Z43puPNmltNOtT6sGjt524Ca8DnqMdHoo9vvPuhduGgmlZQTjgKvD4JxPBrhpTV5JKBcdQecDaKiZa3lEshEMoXqIkhpQj9uQwl6mijGtS9jepoo1psRNarhx2eOX9NQ0C7AH5DF_pkHHgDZxgaXTMhcIRHy-nGZZ1d8Jsw-4zUN_9PRfT7BY1ew8FBVCeGdRE_CU7f_fMlfwDtS87_</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2483813544</pqid></control><display><type>article</type><title>Interleukin-24 protects against liver injury in mouse models</title><source>DOAJ Directory of Open Access Journals</source><source>Web of Science - Science Citation Index Expanded - 2021<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" /></source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><creator>Wang, Hsiao-Hsuan ; Huang, Jian-Hao ; Sue, Min-Hao ; Ho, Wei-Chih ; Hsu, Yu-Hsiang ; Chang, Kung-Chao ; Chang, Ming-Shi</creator><creatorcontrib>Wang, Hsiao-Hsuan ; Huang, Jian-Hao ; Sue, Min-Hao ; Ho, Wei-Chih ; Hsu, Yu-Hsiang ; Chang, Kung-Chao ; Chang, Ming-Shi</creatorcontrib><description>Interleukin-24 (IL-24) binds to two kinds of receptor complexes, namely IL-20R1/IL-20R2 and IL-20R2/IL-22R1, which are also bound by IL-20. IL-20 plays a detrimental role in liver fibrosis. Due to the sharing of receptor complexes, we aimed to determine whether IL-24 also participates in liver fibrosis.
Clinical biopsy specimens from various stages of liver fibrosis were used to analyze IL-24 expression. IL-24 protein was administered to mice with thioacetamide (TAA)-induced liver injury. The direct effects of IL-24 on mouse primary hepatocytes or hepatic stellate cells (HSCs) were analyzed. Wild-type, IL-20R1-, and IL20R2-deficient mice were used to establish a model of acute TAA-induced liver injury.
Among patients with more severe liver fibrosis, there was a reduced IL-24/IL-20 ratio. Administration of IL-24 protein protected mice from TAA-induced liver injury and reduction of liver inflammation by antioxidant effects. IL-24 protected hepatocytes from TAA-induced apoptosis and prevented liver fibrosis through the inhibition of the HSCs activation. The protective role of IL-24 acted on liver cells were mainly IL-20R1-independent. IL-20R2-deficient mice exhibited more severe liver injury upon TAA treatment, thus confirming the protective role of IL-24.
IL-24 plays a key protective role in the progression of liver injury and has therapeutic potential for treating liver injuries.
This work was supported by the Ministry of Science and Technology of Taiwan (MOST 106–2320-B-006–024) and Taiwan Liver Disease Prevention & Treatment Research Foundation.</description><identifier>ISSN: 2352-3964</identifier><identifier>EISSN: 2352-3964</identifier><identifier>DOI: 10.1016/j.ebiom.2021.103213</identifier><identifier>PMID: 33508745</identifier><language>eng</language><publisher>AMSTERDAM: Elsevier B.V</publisher><subject><![CDATA[General & Internal Medicine ; Hepatic stellate cells ; Interleukin-24 ; Life Sciences & Biomedicine ; Liver fibrosis ; Medicine, General & Internal ; Medicine, Research & Experimental ; Research & Experimental Medicine ; Research Paper ; Science & Technology ; Thioacetamide-induced liver injury]]></subject><ispartof>EBioMedicine, 2021-02, Vol.64, p.103213-103213, Article 103213</ispartof><rights>2021 The Authors</rights><rights>Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved.</rights><rights>2021 The Authors 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>true</woscitedreferencessubscribed><woscitedreferencescount>13</woscitedreferencescount><woscitedreferencesoriginalsourcerecordid>wos000624441600011</woscitedreferencesoriginalsourcerecordid><citedby>FETCH-LOGICAL-c525t-27f2f170128d23565f358442df91728ee5a95564bed2cecec2416656b2cde3713</citedby><cites>FETCH-LOGICAL-c525t-27f2f170128d23565f358442df91728ee5a95564bed2cecec2416656b2cde3713</cites><orcidid>0000-0001-9577-0400 ; 0000-0003-2870-3675</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841303/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841303/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,315,728,781,785,865,886,2103,2115,27929,27930,39263,53796,53798</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33508745$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Hsiao-Hsuan</creatorcontrib><creatorcontrib>Huang, Jian-Hao</creatorcontrib><creatorcontrib>Sue, Min-Hao</creatorcontrib><creatorcontrib>Ho, Wei-Chih</creatorcontrib><creatorcontrib>Hsu, Yu-Hsiang</creatorcontrib><creatorcontrib>Chang, Kung-Chao</creatorcontrib><creatorcontrib>Chang, Ming-Shi</creatorcontrib><title>Interleukin-24 protects against liver injury in mouse models</title><title>EBioMedicine</title><addtitle>EBIOMEDICINE</addtitle><addtitle>EBioMedicine</addtitle><description>Interleukin-24 (IL-24) binds to two kinds of receptor complexes, namely IL-20R1/IL-20R2 and IL-20R2/IL-22R1, which are also bound by IL-20. IL-20 plays a detrimental role in liver fibrosis. Due to the sharing of receptor complexes, we aimed to determine whether IL-24 also participates in liver fibrosis.
Clinical biopsy specimens from various stages of liver fibrosis were used to analyze IL-24 expression. IL-24 protein was administered to mice with thioacetamide (TAA)-induced liver injury. The direct effects of IL-24 on mouse primary hepatocytes or hepatic stellate cells (HSCs) were analyzed. Wild-type, IL-20R1-, and IL20R2-deficient mice were used to establish a model of acute TAA-induced liver injury.
Among patients with more severe liver fibrosis, there was a reduced IL-24/IL-20 ratio. Administration of IL-24 protein protected mice from TAA-induced liver injury and reduction of liver inflammation by antioxidant effects. IL-24 protected hepatocytes from TAA-induced apoptosis and prevented liver fibrosis through the inhibition of the HSCs activation. The protective role of IL-24 acted on liver cells were mainly IL-20R1-independent. IL-20R2-deficient mice exhibited more severe liver injury upon TAA treatment, thus confirming the protective role of IL-24.
IL-24 plays a key protective role in the progression of liver injury and has therapeutic potential for treating liver injuries.
This work was supported by the Ministry of Science and Technology of Taiwan (MOST 106–2320-B-006–024) and Taiwan Liver Disease Prevention & Treatment Research Foundation.</description><subject>General & Internal Medicine</subject><subject>Hepatic stellate cells</subject><subject>Interleukin-24</subject><subject>Life Sciences & Biomedicine</subject><subject>Liver fibrosis</subject><subject>Medicine, General & Internal</subject><subject>Medicine, Research & Experimental</subject><subject>Research & Experimental Medicine</subject><subject>Research Paper</subject><subject>Science & Technology</subject><subject>Thioacetamide-induced liver injury</subject><issn>2352-3964</issn><issn>2352-3964</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>HGBXW</sourceid><sourceid>DOA</sourceid><recordid>eNqNUl2L1DAULaK4y7q_QJA-CtIxn20HVFgGPwYWfNHnkCa3Y2qbjEk6sv_eO9tx2H0RCeSGm3POvbknRfGSkhUltH47rKBzYVoxwihmOKP8SXHJuGQVX9fi6YPzRXGd0kAIoVJgsn1eXHAuSdsIeVm82_oMcYT5p_MVE-U-hgwmp1LvtPMpl6M7QCydH-Z4h6GcwpwAdwtjelE86_WY4PoUr4rvnz5-23ypbr9-3m5ubisjmcwVa3rW04ZQ1lpsoJY9diEEs_2aNqwFkHotZS06sMwALiZoXcu6Y8YCbyi_KraLrg16UPvoJh3vVNBO3SdC3CkdszMjKGuIbZjpLNYSzPCW0Z43puPNmltNOtT6sGjt524Ca8DnqMdHoo9vvPuhduGgmlZQTjgKvD4JxPBrhpTV5JKBcdQecDaKiZa3lEshEMoXqIkhpQj9uQwl6mijGtS9jepoo1psRNarhx2eOX9NQ0C7AH5DF_pkHHgDZxgaXTMhcIRHy-nGZZ1d8Jsw-4zUN_9PRfT7BY1ew8FBVCeGdRE_CU7f_fMlfwDtS87_</recordid><startdate>20210201</startdate><enddate>20210201</enddate><creator>Wang, Hsiao-Hsuan</creator><creator>Huang, Jian-Hao</creator><creator>Sue, Min-Hao</creator><creator>Ho, Wei-Chih</creator><creator>Hsu, Yu-Hsiang</creator><creator>Chang, Kung-Chao</creator><creator>Chang, Ming-Shi</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>BLEPL</scope><scope>DTL</scope><scope>HGBXW</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-9577-0400</orcidid><orcidid>https://orcid.org/0000-0003-2870-3675</orcidid></search><sort><creationdate>20210201</creationdate><title>Interleukin-24 protects against liver injury in mouse models</title><author>Wang, Hsiao-Hsuan ; Huang, Jian-Hao ; Sue, Min-Hao ; Ho, Wei-Chih ; Hsu, Yu-Hsiang ; Chang, Kung-Chao ; Chang, Ming-Shi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c525t-27f2f170128d23565f358442df91728ee5a95564bed2cecec2416656b2cde3713</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>General & Internal Medicine</topic><topic>Hepatic stellate cells</topic><topic>Interleukin-24</topic><topic>Life Sciences & Biomedicine</topic><topic>Liver fibrosis</topic><topic>Medicine, General & Internal</topic><topic>Medicine, Research & Experimental</topic><topic>Research & Experimental Medicine</topic><topic>Research Paper</topic><topic>Science & Technology</topic><topic>Thioacetamide-induced liver injury</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Hsiao-Hsuan</creatorcontrib><creatorcontrib>Huang, Jian-Hao</creatorcontrib><creatorcontrib>Sue, Min-Hao</creatorcontrib><creatorcontrib>Ho, Wei-Chih</creatorcontrib><creatorcontrib>Hsu, Yu-Hsiang</creatorcontrib><creatorcontrib>Chang, Kung-Chao</creatorcontrib><creatorcontrib>Chang, Ming-Shi</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Web of Science Core Collection</collection><collection>Science Citation Index Expanded</collection><collection>Web of Science - Science Citation Index Expanded - 2021</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>EBioMedicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Hsiao-Hsuan</au><au>Huang, Jian-Hao</au><au>Sue, Min-Hao</au><au>Ho, Wei-Chih</au><au>Hsu, Yu-Hsiang</au><au>Chang, Kung-Chao</au><au>Chang, Ming-Shi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Interleukin-24 protects against liver injury in mouse models</atitle><jtitle>EBioMedicine</jtitle><stitle>EBIOMEDICINE</stitle><addtitle>EBioMedicine</addtitle><date>2021-02-01</date><risdate>2021</risdate><volume>64</volume><spage>103213</spage><epage>103213</epage><pages>103213-103213</pages><artnum>103213</artnum><issn>2352-3964</issn><eissn>2352-3964</eissn><abstract>Interleukin-24 (IL-24) binds to two kinds of receptor complexes, namely IL-20R1/IL-20R2 and IL-20R2/IL-22R1, which are also bound by IL-20. IL-20 plays a detrimental role in liver fibrosis. Due to the sharing of receptor complexes, we aimed to determine whether IL-24 also participates in liver fibrosis.
Clinical biopsy specimens from various stages of liver fibrosis were used to analyze IL-24 expression. IL-24 protein was administered to mice with thioacetamide (TAA)-induced liver injury. The direct effects of IL-24 on mouse primary hepatocytes or hepatic stellate cells (HSCs) were analyzed. Wild-type, IL-20R1-, and IL20R2-deficient mice were used to establish a model of acute TAA-induced liver injury.
Among patients with more severe liver fibrosis, there was a reduced IL-24/IL-20 ratio. Administration of IL-24 protein protected mice from TAA-induced liver injury and reduction of liver inflammation by antioxidant effects. IL-24 protected hepatocytes from TAA-induced apoptosis and prevented liver fibrosis through the inhibition of the HSCs activation. The protective role of IL-24 acted on liver cells were mainly IL-20R1-independent. IL-20R2-deficient mice exhibited more severe liver injury upon TAA treatment, thus confirming the protective role of IL-24.
IL-24 plays a key protective role in the progression of liver injury and has therapeutic potential for treating liver injuries.
This work was supported by the Ministry of Science and Technology of Taiwan (MOST 106–2320-B-006–024) and Taiwan Liver Disease Prevention & Treatment Research Foundation.</abstract><cop>AMSTERDAM</cop><pub>Elsevier B.V</pub><pmid>33508745</pmid><doi>10.1016/j.ebiom.2021.103213</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0001-9577-0400</orcidid><orcidid>https://orcid.org/0000-0003-2870-3675</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2352-3964 |
| ispartof | EBioMedicine, 2021-02, Vol.64, p.103213-103213, Article 103213 |
| issn | 2352-3964 2352-3964 |
| language | eng |
| recordid | cdi_webofscience_primary_000624441600011CitationCount |
| source | DOAJ Directory of Open Access Journals; Web of Science - Science Citation Index Expanded - 2021<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" />; EZB-FREE-00999 freely available EZB journals; PubMed Central; Alma/SFX Local Collection |
| subjects | General & Internal Medicine Hepatic stellate cells Interleukin-24 Life Sciences & Biomedicine Liver fibrosis Medicine, General & Internal Medicine, Research & Experimental Research & Experimental Medicine Research Paper Science & Technology Thioacetamide-induced liver injury |
| title | Interleukin-24 protects against liver injury in mouse models |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-16T10%3A08%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_webof&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Interleukin-24%20protects%20against%20liver%20injury%20in%20mouse%20models&rft.jtitle=EBioMedicine&rft.au=Wang,%20Hsiao-Hsuan&rft.date=2021-02-01&rft.volume=64&rft.spage=103213&rft.epage=103213&rft.pages=103213-103213&rft.artnum=103213&rft.issn=2352-3964&rft.eissn=2352-3964&rft_id=info:doi/10.1016/j.ebiom.2021.103213&rft_dat=%3Cproquest_webof%3E2483813544%3C/proquest_webof%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2483813544&rft_id=info:pmid/33508745&rft_els_id=S2352396421000062&rft_doaj_id=oai_doaj_org_article_dc0d72cbd28d42c3821f37cb3793da0b&rfr_iscdi=true |